Pfizer (PFE) stock, Alnylam (ALNY) stock and BridgeBio (BBIO) stock jump after a trial setback for an ATTE-CM drug from Astra ...

Could this be the secret to Pfizer's rebound strategy?

Eplontersen’s failure in transthyretin-mediated amyloidosis cardiomyopathy caught Wall Street analysts by surprise and ...

AstraZeneca stock crashed Thursday after its Ionis-partnered treatment for a rare heart disease failed in Phase 3 testing.

A recent study pinpoints the two leading GLP-1 manufacturers as the top pharma companies cited the most across leading AI ...

BenchSci, a leading provider of AI software for biopharma research and development, today announced the appointment of Dr. Mikael Dolsten, M.D., Ph.D., as Chairman of its Board of Directors, effective ...

Can a pharmaceutical company build "power brands" the way consumer giants do? In this exclusive Fortune India: In ...

A 7% dividend yield will grab your attention, but be sure to read the fine print.

The infrastructure moment for AI-driven drug discovery continues to accelerate, with billion-dollar investments flowing into ...

GSK has walked away from a $2.2 billion biobucks neurodegenerative disease pact with Alector that has seen both drugs ...

New York City’s buildings commissioner said late Tuesday that the building was stable for now, hours after officials set up a ...

The building on East 42nd Street, the former headquarters of Pfizer, was being converted to apartments. Several upper floors ...